Caplin Point Laboratories Limited (CAPLIPOINT.NS) NSE

1,837.50

+25.4(+1.40%)

Updated at January 14 02:41PM

Currency In INR

Valuation

Market Cap150.98B
Enterprise Value145.12B
P/E Ratio23.79
PEG Ratio5.71
Price/Sales Ratio6.86
Price/Book Ratio4.43
Enterprise/Revenue6.55
Enterprise/EBITDA18.34

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.29
Operating Margin0.42

Management Effectiveness

Return On Assets0.17
Return On Equity0.21

Income Statement

Revenue19.4B
Revenue/Share268.61
Gross Profit11.38B
EBITDA6.49B
Net Income5.36B
Diluted EPS70.25

Balance Sheet

Total Cash10.17B
Total Cash/Share133.82
Total Debt53.1M
Total Debt/Equity0
Current Ratio8.17
Book Value Per Share420.85

Price History

52-Week Change-21.04
52-Week High2,395
52-Week Low1,599
Moving Average 50 Days1,910.75
Moving Average 200 Days2,023.87

Statistics

Average Volume68,249.5
Shares Outstanding76.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate6
Trailing Annual Dividend Yield0.33
Payout Ratio0
Last Split Factor5:1
Last Split DateOctober 19, 2016